ES2329815T3 - S-mirtazapina para el tratamiento de sofocos. - Google Patents

S-mirtazapina para el tratamiento de sofocos. Download PDF

Info

Publication number
ES2329815T3
ES2329815T3 ES05808013T ES05808013T ES2329815T3 ES 2329815 T3 ES2329815 T3 ES 2329815T3 ES 05808013 T ES05808013 T ES 05808013T ES 05808013 T ES05808013 T ES 05808013T ES 2329815 T3 ES2329815 T3 ES 2329815T3
Authority
ES
Spain
Prior art keywords
treatment
mirtazapine
rats
score
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05808013T
Other languages
English (en)
Spanish (es)
Inventor
B.W.M.M. Bernardus Peeters
Anton Egbert Peter Adang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2329815(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of ES2329815T3 publication Critical patent/ES2329815T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES05808013T 2004-11-15 2005-11-14 S-mirtazapina para el tratamiento de sofocos. Expired - Lifetime ES2329815T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
EP04105778 2004-11-15

Publications (1)

Publication Number Publication Date
ES2329815T3 true ES2329815T3 (es) 2009-12-01

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05808013T Expired - Lifetime ES2329815T3 (es) 2004-11-15 2005-11-14 S-mirtazapina para el tratamiento de sofocos.

Country Status (30)

Country Link
US (4) US20070265245A1 (enExample)
EP (1) EP1814555B1 (enExample)
JP (1) JP2008519810A (enExample)
KR (1) KR20070085470A (enExample)
CN (2) CN102772414A (enExample)
AR (1) AR053780A1 (enExample)
AT (1) ATE439843T1 (enExample)
AU (1) AU2005303778B2 (enExample)
BR (1) BRPI0517818A2 (enExample)
CA (1) CA2587283C (enExample)
CY (1) CY1110538T1 (enExample)
DE (1) DE602005016141D1 (enExample)
DK (1) DK1814555T3 (enExample)
ES (1) ES2329815T3 (enExample)
HR (1) HRP20090513T1 (enExample)
IL (1) IL182767A (enExample)
MX (1) MX2007005827A (enExample)
MY (1) MY144089A (enExample)
NO (1) NO20072285L (enExample)
NZ (1) NZ554858A (enExample)
PE (1) PE20061051A1 (enExample)
PL (1) PL1814555T3 (enExample)
PT (1) PT1814555E (enExample)
RS (1) RS51138B (enExample)
RU (1) RU2396957C2 (enExample)
SI (1) SI1814555T1 (enExample)
TW (1) TW200631584A (enExample)
UA (1) UA88655C2 (enExample)
WO (1) WO2006051111A1 (enExample)
ZA (1) ZA200703884B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
CA2644985A1 (en) * 2006-03-06 2007-09-13 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
US20100129425A1 (en) * 2006-11-22 2010-05-27 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
EP3261645B1 (en) 2015-02-27 2021-04-28 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
EP3630102B1 (en) * 2017-05-25 2024-08-14 Glytech LLC. Formulations for treatment of post-traumatic stress disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
DE69913116T2 (de) * 1998-04-02 2004-06-03 Akzo Nobel N.V. Orale flüssige lösung enthaltend das antidepressivum mirtazapine
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
CN101056641A (zh) 2007-10-17
US20130225559A1 (en) 2013-08-29
TW200631584A (en) 2006-09-16
CN102772414A (zh) 2012-11-14
RU2007122391A (ru) 2008-12-20
DE602005016141D1 (de) 2009-10-01
CY1110538T1 (el) 2015-04-29
MY144089A (en) 2011-08-15
CA2587283C (en) 2013-01-15
HRP20090513T1 (hr) 2009-10-31
PT1814555E (pt) 2009-09-30
PE20061051A1 (es) 2006-10-26
DK1814555T3 (da) 2009-12-07
BRPI0517818A2 (pt) 2010-03-16
CA2587283A1 (en) 2006-05-18
IL182767A0 (en) 2007-09-20
SI1814555T1 (sl) 2009-12-31
RU2396957C2 (ru) 2010-08-20
PL1814555T3 (pl) 2010-01-29
AU2005303778A1 (en) 2006-05-18
US20100267694A1 (en) 2010-10-21
IL182767A (en) 2011-07-31
KR20070085470A (ko) 2007-08-27
NZ554858A (en) 2009-10-30
US20070265245A1 (en) 2007-11-15
US20120302552A1 (en) 2012-11-29
UA88655C2 (ru) 2009-11-10
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
ATE439843T1 (de) 2009-09-15
AU2005303778B2 (en) 2011-02-17
HK1104235A1 (en) 2008-01-11
EP1814555A1 (en) 2007-08-08
RS51138B (sr) 2010-10-31
NO20072285L (no) 2007-06-13
MX2007005827A (es) 2007-07-20
JP2008519810A (ja) 2008-06-12
EP1814555B1 (en) 2009-08-19
AR053780A1 (es) 2007-05-23

Similar Documents

Publication Publication Date Title
ES2244418T3 (es) Composiciones de apomorfina y sidenalfilo y utilizacion de los mismos para el tratamiento de la disfuncion erectil.
ES2272827T3 (es) Parche terapeutico transdermico con capsaicina y analogos de capsaicina.
ES2241651T3 (es) Utilizacion de la nicotina o de sus derivados y de la l-dopa en un medicamento destinado al tratamiento de enfermedades neurologicas, especialmente la enfermedad de parkinson.
US20120302552A1 (en) S-mirtazapine for the treatment of hot flush
RO116866B1 (ro) Compozitie pentru modularea raspunsului sexual
ES2762113T3 (es) Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor
ES2383433T3 (es) Formulación farmacéutica de apomorfina para administración bucal
ES2270517T3 (es) Terapia de combinacion para modular la respuesta sexual humana.
JP2009539895A (ja) ＡＣｈＥ−ＮＭＤＡ組み合わせウェーハ
JP2009539893A (ja) 組合せウェーハ
WO2008120966A1 (es) Composición farmacéutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgésico opiáceo para el manejo del dolor.
ES2813084T3 (es) Composiciones y métodos no hormonales para la anticoncepción masculina que comprenden (R)-Silodosina
US20180289708A1 (en) Low dose oral dipyridamole compositions and uses thereof
JPS61502751A (ja) アザタジンの経度デリバリ−
ES2668943T3 (es) Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz
RU2006110550A (ru) Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна
ES2388786T3 (es) Uso de estimulantes psicomotores y composiciones que los contienen en un método de tratamiento de mamíferos placentarios parturientes para reducir agotamiento materno y/o uterino
HK1104235B (en) S-mirtazapine for the treatment of hot flush
US20100330212A1 (en) Skin sensitizer delivery system
Clark et al. What's the Alternative?: Orthodox and Complementary Remedies for Common Complaints
WO2024144678A1 (en) Orally disintegrating tablets (odt) formulations for the treatment of flu, common cold and allergic symptoms
CN106138069A (zh) 作为治疗来自非角化复层上皮组织的不适的局部药剂的1-二仲丁基膦酰基戊烷